These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 22064513)

  • 1. Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis.
    Tan F; Jiang Y; Sun N; Chen Z; Lv Y; Shao K; Li N; Qiu B; Gao Y; Li B; Tan X; Zhou F; Wang Z; Ding D; Wang J; Sun J; Hang J; Shi S; Feng X; He F; He J
    Mol Cell Proteomics; 2012 Feb; 11(2):M111.008821. PubMed ID: 22064513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of new membrane-associated proteins overexpressed in small-cell lung cancer.
    Ocak S; Friedman DB; Chen H; Ausborn JA; Hassanein M; Detry B; Weynand B; Aboubakar F; Pilette C; Sibille Y; Massion PP
    J Thorac Oncol; 2014 Mar; 9(3):324-36. PubMed ID: 24518087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of FOXC1 is associated with poor clinical outcome in non-small cell lung cancer patients.
    Wei LX; Zhou RS; Xu HF; Wang JY; Yuan MH
    Tumour Biol; 2013 Apr; 34(2):941-6. PubMed ID: 23264086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H; Zeng F; Xu L; Liu X; Huang Y
    Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of RUNX2 expression in patients with nonsmall cell lung cancer: a 5-year follow-up study.
    Li H; Zhou RJ; Zhang GQ; Xu JP
    Tumour Biol; 2013 Jun; 34(3):1807-12. PubMed ID: 23471668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isocitrate dehydrogenase 1 is a novel plasma biomarker for the diagnosis of non-small cell lung cancer.
    Sun N; Chen Z; Tan F; Zhang B; Yao R; Zhou C; Li J; Gao Y; Liu Z; Tan X; Zhou F; He MY; Shao K; Li N; Qiu B; Sun J; Yu Y; Wang S; Zhao Y; Shi X; He J
    Clin Cancer Res; 2013 Sep; 19(18):5136-45. PubMed ID: 24046070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
    Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of MAC30 is associated with poor clinical outcome in human non-small-cell lung cancer.
    Han KY; Gu X; Wang HR; Liu D; Lv FZ; Li JN
    Tumour Biol; 2013 Apr; 34(2):821-5. PubMed ID: 23229099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of annexin II expression in non-small cell lung cancer.
    Luo CH; Liu QQ; Zhang PF; Li MY; Chen ZC; Liu YF
    Clin Transl Oncol; 2013 Nov; 15(11):938-46. PubMed ID: 23529818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z; Guo Y
    Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of SH2B1 adaptor protein expression in non-small cell lung cancer.
    Zhang H; Duan CJ; Chen W; Wang SQ; Zhang SK; Dong S; Cheng YD; Zhang CF
    Asian Pac J Cancer Prev; 2012; 13(5):2355-62. PubMed ID: 22901222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midkine mRNA level in peripheral blood mononuclear cells is a novel biomarker for primary non-small cell lung cancer: a prospective study.
    Ma Z; Li H; Wang B; Shen Q; Cui E; Min L; Qian F; Ping J; Dai L
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):557-62. PubMed ID: 23224432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival.
    Ni SS; Zhang J; Zhao WL; Dong XC; Wang JL
    Tumour Biol; 2013 Jun; 34(3):1813-8. PubMed ID: 23475633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT5 facilitates cancer cell growth and drug resistance in non-small cell lung cancer.
    Lu W; Zuo Y; Feng Y; Zhang M
    Tumour Biol; 2014 Nov; 35(11):10699-705. PubMed ID: 25070488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of high mobility group box - B1 (HMGB-1) and matrix metalloproteinase-9 (MMP-9) in non-small cell lung cancer (NSCLC).
    Wang JL; Wu DW; Cheng ZZ; Han WZ; Xu SW; Sun NN
    Asian Pac J Cancer Prev; 2014; 15(12):4865-9. PubMed ID: 24998555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
    Xing R; Chen KB; Xuan Y; Feng C; Xue M; Zeng YC
    Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical role of small glutamine-rich tetratricopeptide repeat (TPR)-containing protein alpha (SGTA) as a novel cell cycle protein in NSCLC.
    Xue Q; Lv L; Wan C; Chen B; Li M; Ni T; Liu Y; Liu Y; Cong X; Zhou Y; Ni R; Mao G
    J Cancer Res Clin Oncol; 2013 Sep; 139(9):1539-49. PubMed ID: 23857189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis.
    Mei YP; Liao JP; Shen J; Yu L; Liu BL; Liu L; Li RY; Ji L; Dorsey SG; Jiang ZR; Katz RL; Wang JY; Jiang F
    Oncogene; 2012 May; 31(22):2794-804. PubMed ID: 21986946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion.
    Marwitz S; Depner S; Dvornikov D; Merkle R; Szczygieł M; Müller-Decker K; Lucarelli P; Wäsch M; Mairbäurl H; Rabe KF; Kugler C; Vollmer E; Reck M; Scheufele S; Kröger M; Ammerpohl O; Siebert R; Goldmann T; Klingmüller U
    Cancer Res; 2016 Jul; 76(13):3785-801. PubMed ID: 27197161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of Toll-like receptor 5 correlates with better prognosis in non-small-cell lung cancer: an anti-tumor effect of TLR5 signaling in non-small cell lung cancer.
    Zhou H; Chen JH; Hu J; Luo YZ; Li F; Xiao L; Zhong MZ
    J Cancer Res Clin Oncol; 2014 Apr; 140(4):633-43. PubMed ID: 24549739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.